Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > To ALL involved with LABS...then WHO do you think is the
View:
Post by subaru1i on Mar 23, 2024 9:20am

To ALL involved with LABS...then WHO do you think is the

'large traditional global pharmaceutical partner' that CEO Medipharm Labs has mentioned several times? 

PLEASE...speak up loudly on this board and share your thoughts of who YOU think is that company partner company then because LABS has a pipeline of over 20 STRONG clinical trials so PLEASE speak loudly and share your thoughs of which global pharma is going to COMMERCIALIZE.
Comment by QContinuum1 on Mar 23, 2024 11:50am
It is not, nor has it ever really been, a mystery on who the partner is.  It is one of these  listed as defendant: https://dockets.justia.com/docket/new-jersey/njdce/2:2023cv03914/515278 And we know, as fact, it is one of these since it was confirmed by Strachan that the ANDA is associated with Epidiolex and only that.  My bet is Apotex simply because of the Canadian angle. The ...more  
Comment by mdjbrown on Mar 23, 2024 7:30pm
QC1, dont forget about Brazil.  Large as you say or top tier pharma may be subjective, but regardless Medipharm is making headway to become a top producer in a country desperately looking for alternatives. We know Labs partnered with XLR8 a few years ago in Brazil, so who is the newest top-tier PharmaCo? “the Company entered into a supply agreement with a top-tier generic pharmaceutical ...more  
Comment by subaru1i on Mar 23, 2024 8:40pm
Brazil is nice but Brazil was referenced to as 'top tier' generic drug maker which is very different from a large tradional global pharmaceutical partner.   Any generic drug maker is second tier nomenclature to traditioal global pharma.   Lets celebrate what 'tradition' means as in 175 years of becoming a global pharma https://www.youtube.com/watch?v ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities